Sugi Predict

Sugi Predict / Compounds / SCHEMBL4139033

SCHEMBL4139033

SCHEMBL4139033

CSc1nc2ccccc2n2cc(-c3ccccc3)cc12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 6/20 0.43
▸ KDM4E B2RXH2 5/20 0.43
▸ HPGD P15428 5/20 0.43
▸ GAA P10253 2/20 0.43
▸ LMNA P02545 2/20 0.43
▸ GLA P06280 1/20 0.43
▸ L3MBTL1 Q9Y468 1/20 0.43
▸ ADORA2A P29274 2/20 0.40
▸ PTGS2 P35354 1/20 0.39
▸ NR1I3 Q14994 2/20 0.39
▸ HSD17B10 Q99714 2/20 0.38
▸ TP53 P04637 2/20 0.37
▸ MAPT P10636 2/20 0.37
▸ PTPN2 P17706 1/20 0.37
▸ PTPN1 P18031 1/20 0.37
▸ PDE6D O43924 1/20 0.37
▸ ALDH2 P05091 1/20 0.37
▸ ALDH3A1 P30838 1/20 0.37
▸ TSHR P16473 1/20 0.37
▸ CYP1A2 P05177 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4146645 0.77 TYMS (0.50) ALDH1A1KDM4EHPGDGAALMNA
SCHEMBL4134603 0.77 ALDH1A1 (0.43) ALDH1A1KDM4EHPGDGAALMNA
SCHEMBL13872493 0.73 LCK (0.46) ALDH1A1KDM4EHPGDGAALMNA
SCHEMBL4131814 0.72 LCK (0.58) KDM4EHPGDGAALMNAHSD17B10
SCHEMBL11910203 0.71 MAP4K4 (0.44) ALDH1A1KDM4EGAAGLAL3MBTL1
SCHEMBL4139190 0.70 KDM4E (0.56) ALDH1A1KDM4EHPGDLMNAADORA2A
SCHEMBL4139066 0.68 MAPK8 (0.58) ALDH1A1KDM4EHPGDL3MBTL1ADORA2A
SCHEMBL29893534 0.66 ALDH1A1 (0.47) ALDH1A1KDM4EHPGDGAALMNA
SCHEMBL28238914 0.65 KDM4E (0.51) ALDH1A1KDM4EHPGDGAALMNA
SCHEMBL13854079 0.65 MAPT (0.53) ALDH1A1KDM4EHPGDGAALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090093476-A1 PYRROLO[1,2-A]QUINOXALINE DERIVATIVES AS ADENOSINE A3 RECEPTOR MODULATORS AND USES THEREOF FAUST PHARMACEUTICALS (FR) 2009-04-09 — — US disclosed
US-20090093476-A1 PYRROLO[1,2-A]QUINOXALINE DERIVATIVES AS ADENOSINE A3 RECEPTOR MODULATORS AND USES THEREOF FAUST PHARMACEUTICALS (FR) 2009-04-09 — — US disclosed
US-20090093476-A1 PYRROLO[1,2-A]QUINOXALINE DERIVATIVES AS ADENOSINE A3 RECEPTOR MODULATORS AND USES THEREOF FAUST PHARMACEUTICALS (FR) 2009-04-09 — — US disclosed
WO-2007071379-A1 PYRROLO [l,2-A]QUINOXALINE DERIVATIVES AS ADENOSINE A3 RECEPTOR MODULATORS AND USES THEREOF FAUST PHARMACEUTICALS (FR) 2007-06-28 — — WO disclosed
EP-1798233-A1 Pyrrolo[1,2-a]quinoxaline derivatives as Adenosine A3 receptor modulators and uses thereof Faust Pharmaceuticals (FR) 2007-06-20 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090093476-A1 PYRROLO[1,2-A]QUINOXALINE DERIVATIVES AS ADENOSINE A3 RECEPTOR MODULATORS AND USES THEREOF ADORA3, ADORA2A, ADORA1 ALDH1A1 1300/4885KDM4E 3489/4885HPGD 909/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.